Differential Expression Analysis
YS / P Comparison
Note: The Fold Change value for up-regulated genes is displayed in red; down-regulated values are displayed in blue.
| Gene | Annotation | pval | Fold Change (log2ratio) |
|---|---|---|---|
| lyve1 | lymphatic vessel endothelial hyaluronan receptor 1 | 2.094e-5 | 4.628e+0 |
| hapln1 | hyaluronan and proteoglycan link protein 1 | 1.129e-6 | 4.378e+0 |
| ttr | transthyretin | 5.551e-3 | 4.250e+0 |
| sall4 | sal-like 4 (Drosophila) | 2.216e-4 | 3.730e+0 |
| prtg | protogenin homolog (Gallus gallus) | 4.631e-8 | 3.701e+0 |
| loc100044263 | hypothetical protein LOC100044263 | 1.071e-2 | 3.646e+0 |
| d030007l05rik | RIKEN cDNA D030007L05 gene | 1.428e-4 | 3.475e+0 |
| hbb-bh1 | hemoglobin Z, beta-like embryonic chain | 1.351e-2 | 3.465e+0 |
| gm784 | gene model 784, (NCBI) | 1.305e-4 | 3.216e+0 |
| cubn | cubilin (intrinsic factor-cobalamin receptor) | 2.142e-2 | 3.206e+0 |
| apoa1 | apolipoprotein A-I | 7.591e-3 | 3.133e+0 |
| rbp4 | retinol binding protein 4, plasma | 1.493e-2 | 3.085e+0 |
| clec1b | C-type lectin domain family 1, member b | 6.707e-4 | 3.059e+0 |
| spink3 | serine peptidase inhibitor, Kazal type 3 | 8.553e-3 | 2.896e+0 |
| gucy1a3 | guanylate cyclase 1, soluble, alpha 3 | 2.023e-6 | 2.869e+0 |
| heph | hephaestin | 1.570e-4 | 2.683e+0 |
| fbp2 | fructose bisphosphatase 2 | 3.868e-6 | 2.516e+0 |
| tmem163 | transmembrane protein 163 | 6.851e-6 | 2.422e+0 |
| sox18 | SRY-box containing gene 18 | 2.891e-3 | 2.418e+0 |
| wasf1 | WASP family 1 | 1.125e-5 | 2.393e+0 |
| gfi1b | growth factor independent 1B | 1.130e-8 | 2.380e+0 |
| rhoj | ras homolog gene family, member J | 5.124e-4 | 2.372e+0 |
| 9430041p20rik | RIKEN cDNA 9430041P20 gene | 1.895e-3 | 2.314e+0 |
| fgf13 | fibroblast growth factor 13 | 8.845e-6 | 2.295e+0 |
| clu | clusterin | 2.264e-3 | 2.259e+0 |
| trim71 | tripartite motif-containing 71 | 2.108e-5 | 2.229e+0 |
| hist1h2ae | histone cluster 1, H2ae | 1.612e-2 | 2.209e+0 |
| cldn5 | claudin 5 | 1.970e-2 | 2.173e+0 |
| kdr | kinase insert domain protein receptor | 4.883e-3 | 2.166e+0 |
| zfpm2 | zinc finger protein, multitype 2 | 7.033e-8 | 2.117e+0 |
| f730015k02rik | RIKEN cDNA F730015K02 gene | 3.712e-2 | 2.116e+0 |
| mest | mesoderm specific transcript | 3.319e-2 | 2.096e+0 |
| tspan12 | tetraspanin 12 | 9.975e-5 | 2.079e+0 |
| lin28 | lin-28 homolog (C. elegans) | 3.812e-4 | 2.062e+0 |
| mrvi1 | MRV integration site 1 | 3.769e-3 | 2.026e+0 |
| ottmusg00000016321 | predicted gene, OTTMUSG00000016321 | 6.825e-5 | 2.013e+0 |
| gap43 | growth associated protein 43 | 6.408e-4 | 2.002e+0 |
| cd53 | CD53 antigen | 3.556e-3 | -2.005e+0 |
| af251705 | cDNA sequence AF251705 | 2.293e-2 | -2.007e+0 |
| napsa | napsin A aspartic peptidase | 5.312e-5 | -2.009e+0 |
| atp10d | ATPase, class V, type 10D | 3.091e-4 | -2.015e+0 |
| h2-m3 | histocompatibility 2, M region locus 3 | 6.270e-3 | -2.018e+0 |
| ccr9 | chemokine (C-C motif) receptor 9 | 4.139e-5 | -2.021e+0 |
| plac8 | placenta-specific 8 | 2.012e-5 | -2.021e+0 |
| abcg3 | ATP-binding cassette, sub-family G (WHITE), member 3 | 4.273e-3 | -2.022e+0 |
| irf4 | interferon regulatory factor 4 | 3.650e-6 | -2.024e+0 |
| h2-q8 | histocompatibility 2, Q region locus 8 | 3.249e-2 | -2.024e+0 |
| kcnab2 | potassium voltage-gated channel, shaker-related subfamily, beta member 2 | 4.625e-6 | -2.027e+0 |
| 1810033b17rik | RIKEN cDNA 1810033B17 gene | 2.884e-2 | -2.027e+0 |
| metrnl | meteorin, glial cell differentiation regulator-like | 2.204e-3 | -2.030e+0 |
| clcf1 | cardiotrophin-like cytokine factor 1 | 8.025e-4 | -2.031e+0 |
| cish | cytokine inducible SH2-containing protein | 2.409e-6 | -2.038e+0 |
| slc45a3 | solute carrier family 45, member 3 | 8.040e-6 | -2.040e+0 |
| shisa5 | shisa homolog 5 (Xenopus laevis) | 1.969e-5 | -2.040e+0 |
| anxa5 | annexin A5 | 3.493e-3 | -2.046e+0 |
| lsp1 | lymphocyte specific 1 | 5.079e-5 | -2.055e+0 |
| bc023892 | cDNA sequence BC023892 | 2.282e-4 | -2.056e+0 |
| glis3 | GLIS family zinc finger 3 | 2.811e-3 | -2.058e+0 |
| p2rx7 | purinergic receptor P2X, ligand-gated ion channel, 7 | 2.904e-5 | -2.067e+0 |
| 1100001g20rik | RIKEN cDNA 1100001G20 gene | 5.155e-4 | -2.077e+0 |
| n4bp2l1 | NEDD4 binding protein 2-like 1 | 1.309e-3 | -2.080e+0 |
| gm885 | gene model 885, (NCBI) | 3.877e-4 | -2.092e+0 |
| 1700006j14rik | RIKEN cDNA 1700006J14 gene | 8.221e-4 | -2.093e+0 |
| vasn | vasorin | 1.851e-6 | -2.099e+0 |
| ccl3 | chemokine (C-C motif) ligand 3 | 2.178e-2 | -2.102e+0 |
| mx1 | myxovirus (influenza virus) resistance 1 | 3.952e-2 | -2.108e+0 |
| cfp | complement factor properdin | 3.567e-3 | -2.110e+0 |
| ccdc109b | coiled-coil domain containing 109B | 3.179e-2 | -2.115e+0 |
| slfn8 | schlafen 8 | 1.138e-2 | -2.119e+0 |
| eltd1 | EGF, latrophilin seven transmembrane domain containing 1 | 6.136e-5 | -2.121e+0 |
| tmem98 | transmembrane protein 98 | 7.568e-5 | -2.126e+0 |
| qpct | glutaminyl-peptide cyclotransferase (glutaminyl cyclase) | 1.518e-2 | -2.126e+0 |
| hlf | hepatic leukemia factor | 3.905e-5 | -2.127e+0 |
| antxr2 | anthrax toxin receptor 2 | 3.648e-6 | -2.128e+0 |
| zbp1 | Z-DNA binding protein 1 | 2.894e-2 | -2.139e+0 |
| sell | selectin, lymphocyte | 4.320e-4 | -2.150e+0 |
| fyb | FYN binding protein | 1.038e-3 | -2.150e+0 |
| c78513 | EST C78513 | 4.164e-3 | -2.153e+0 |
| bcl3 | B-cell leukemia/lymphoma 3 | 2.967e-6 | -2.153e+0 |
| gpr174 | G protein-coupled receptor 174 | 1.175e-4 | -2.155e+0 |
| 677168 | predicted gene, 677168 | 1.301e-2 | -2.160e+0 |
| gpr160 | G protein-coupled receptor 160 | 5.469e-4 | -2.160e+0 |
| emp1 | epithelial membrane protein 1 | 4.751e-4 | -2.162e+0 |
| shisa2 | shisa homolog 2 (Xenopus laevis) | 6.003e-4 | -2.174e+0 |
| tlr2 | toll-like receptor 2 | 1.938e-2 | -2.182e+0 |
| nfil3 | nuclear factor, interleukin 3, regulated | 5.769e-4 | -2.189e+0 |
| cd84 | CD84 antigen | 9.228e-4 | -2.190e+0 |
| pdk4 | pyruvate dehydrogenase kinase, isoenzyme 4 | 6.483e-7 | -2.192e+0 |
| psap | prosaposin | 4.415e-3 | -2.194e+0 |
| 9030619p08rik | RIKEN cDNA 9030619P08 gene | 2.396e-4 | -2.195e+0 |
| sp100 | nuclear antigen Sp100 | 1.752e-3 | -2.197e+0 |
| spint2 | serine protease inhibitor, Kunitz type 2 | 1.781e-4 | -2.197e+0 |
| srgn | serglycin | 2.161e-6 | -2.197e+0 |
| gsdmd | gasdermin D | 1.844e-4 | -2.201e+0 |
| a430093f15rik | RIKEN cDNA A430093F15 gene | 2.369e-5 | -2.212e+0 |
| fabp4 | fatty acid binding protein 4, adipocyte | 7.731e-3 | -2.215e+0 |
| itgb7 | integrin beta 7 | 4.178e-5 | -2.215e+0 |
| tlr1 | toll-like receptor 1 | 3.580e-2 | -2.225e+0 |
| hist3h2a | histone cluster 3, H2a | 1.629e-4 | -2.225e+0 |
| ms4a7 | membrane-spanning 4-domains, subfamily A, member 7 | 1.090e-2 | -2.257e+0 |
| ifit2 | interferon-induced protein with tetratricopeptide repeats 2 | 2.211e-2 | -2.258e+0 |
| rnf19b | ring finger protein 19B | 3.882e-4 | -2.262e+0 |
| gpr65 | G-protein coupled receptor 65 | 2.886e-3 | -2.263e+0 |
| ab124611 | cDNA sequence AB124611 | 1.336e-2 | -2.264e+0 |
| hist1h2bc | histone cluster 1, H2bc | 4.194e-6 | -2.265e+0 |
| trem1 | triggering receptor expressed on myeloid cells 1 | 4.096e-3 | -2.267e+0 |
| psmb8 | proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) | 5.415e-5 | -2.268e+0 |
| ocln | occludin | 2.433e-3 | -2.281e+0 |
| gpnmb | glycoprotein (transmembrane) nmb | 2.937e-2 | -2.284e+0 |
| nap1l5 | nucleosome assembly protein 1-like 5 | 2.370e-4 | -2.286e+0 |
| ms4a2 | membrane-spanning 4-domains, subfamily A, member 2 | 3.099e-3 | -2.287e+0 |
| atp8b4 | ATPase, class I, type 8B, member 4 | 1.419e-3 | -2.287e+0 |
| rel | reticuloendotheliosis oncogene | 2.609e-5 | -2.289e+0 |
| mlkl | mixed lineage kinase domain-like | 4.850e-4 | -2.294e+0 |
| lgals3bp | lectin, galactoside-binding, soluble, 3 binding protein | 7.273e-3 | -2.295e+0 |
| nefh | neurofilament, heavy polypeptide | 3.999e-4 | -2.299e+0 |
| bank1 | B-cell scaffold protein with ankyrin repeats 1 | 4.067e-4 | -2.302e+0 |
| expi | extracellular proteinase inhibitor | 3.567e-4 | -2.305e+0 |
| kel | Kell blood group | 1.093e-3 | -2.308e+0 |
| ctla2a | cytotoxic T lymphocyte-associated protein 2 alpha | 8.384e-6 | -2.314e+0 |
| cyfip2 | cytoplasmic FMR1 interacting protein 2 | 2.578e-6 | -2.317e+0 |
| hbb-b2 | hemoglobin, beta adult minor chain | 4.870e-3 | -2.317e+0 |
| pmepa1 | prostate transmembrane protein, androgen induced 1 | 3.610e-5 | -2.317e+0 |
| s100a11 | S100 calcium binding protein A11 (calgizzarin) | 1.377e-7 | -2.320e+0 |
| gda | guanine deaminase | 2.160e-2 | -2.320e+0 |
| apobec1 | apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 | 8.265e-3 | -2.325e+0 |
| plaur | plasminogen activator, urokinase receptor | 2.098e-4 | -2.325e+0 |
| pparg | peroxisome proliferator activated receptor gamma | 1.812e-2 | -2.328e+0 |
| d12ertd647e | DNA segment, Chr 12, ERATO Doi 647, expressed | 7.185e-7 | -2.329e+0 |
| oas3 | 2'-5' oligoadenylate synthetase 3 | 4.256e-2 | -2.348e+0 |
| 3830612m24 | hypothetical protein 3830612M24 | 1.170e-5 | -2.351e+0 |
| btg1 | B-cell translocation gene 1, anti-proliferative | 2.212e-5 | -2.353e+0 |
| steap4 | STEAP family member 4 | 4.491e-5 | -2.361e+0 |
| ctse | cathepsin E | 1.941e-4 | -2.362e+0 |
| naip5 | NLR family, apoptosis inhibitory protein 5 | 3.095e-4 | -2.367e+0 |
| ifitm3 | interferon induced transmembrane protein 3 | 1.617e-3 | -2.367e+0 |
| mxd1 | MAX dimerization protein 1 | 1.439e-6 | -2.368e+0 |
| h2-dmb2 | histocompatibility 2, class II, locus Mb2 | 2.993e-3 | -2.369e+0 |
| xaf1 | XIAP associated factor 1 | 3.536e-5 | -2.371e+0 |
| gpr183 | G protein-coupled receptor 183 | 6.056e-5 | -2.375e+0 |
| b230312a22rik | RIKEN cDNA B230312A22 gene | 1.434e-5 | -2.375e+0 |
| nuak2 | NUAK family, SNF1-like kinase, 2 | 6.660e-5 | -2.377e+0 |
| 5830416p10rik | RIKEN cDNA 5830416P10 gene | 8.694e-5 | -2.377e+0 |
| h2-dmb1 | histocompatibility 2, class II, locus Mb1 | 1.949e-2 | -2.381e+0 |
| gna14 | guanine nucleotide binding protein, alpha 14 | 5.223e-7 | -2.387e+0 |
| cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 1.480e-4 | -2.387e+0 |
| padi2 | peptidyl arginine deiminase, type II | 5.576e-5 | -2.394e+0 |
| sdc4 | syndecan 4 | 3.862e-2 | -2.398e+0 |
| irf7 | interferon regulatory factor 7 | 1.009e-2 | -2.402e+0 |
| scpep1 | serine carboxypeptidase 1 | 1.103e-2 | -2.407e+0 |
| anxa1 | annexin A1 | 2.459e-4 | -2.408e+0 |
| gpr137b-ps | G protein-coupled receptor 137B, pseudogene | 1.853e-4 | -2.410e+0 |
| agpat9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | 1.139e-2 | -2.416e+0 |
| nlrp3 | NLR family, pyrin domain containing 3 | 3.937e-3 | -2.423e+0 |
| crip1 | cysteine-rich protein 1 (intestinal) | 2.117e-4 | -2.427e+0 |
| c030046g05 | hypothetical protein C030046G05 | 5.270e-6 | -2.430e+0 |
| cytip | cytohesin 1 interacting protein | 1.878e-5 | -2.433e+0 |
| h2-l | histocompatibility 2, D region | 1.518e-4 | -2.439e+0 |
| p2ry6 | pyrimidinergic receptor P2Y, G-protein coupled, 6 | 3.591e-2 | -2.440e+0 |
| cd86 | CD86 antigen | 2.143e-3 | -2.441e+0 |
| igsf6 | immunoglobulin superfamily, member 6 | 3.947e-3 | -2.441e+0 |
| errfi1 | ERBB receptor feedback inhibitor 1 | 3.355e-3 | -2.449e+0 |
| skil | SKI-like | 1.153e-6 | -2.456e+0 |
| cyp4v3 | cytochrome P450, family 4, subfamily v, polypeptide 3 | 1.433e-3 | -2.456e+0 |
| oosp1 | oocyte secreted protein 1 | 4.489e-4 | -2.463e+0 |
| rbp1 | retinol binding protein 1, cellular | 8.343e-4 | -2.466e+0 |
| adrb2 | adrenergic receptor, beta 2 | 6.383e-4 | -2.477e+0 |
| lgals9 | lectin, galactose binding, soluble 9 | 9.554e-4 | -2.486e+0 |
| slfn10 | schlafen 10 | 8.746e-4 | -2.489e+0 |
| slpi | secretory leukocyte peptidase inhibitor | 1.780e-2 | -2.491e+0 |
| cd300lb | CD300 antigen like family member B | 4.355e-3 | -2.494e+0 |
| tlr13 | toll-like receptor 13 | 1.309e-2 | -2.507e+0 |
| pkib | protein kinase inhibitor beta, cAMP dependent, testis specific | 1.702e-4 | -2.518e+0 |
| il7r | interleukin 7 receptor | 1.229e-2 | -2.520e+0 |
| 3830417a13rik | RIKEN cDNA 3830417A13 gene | 3.259e-2 | -2.529e+0 |
| lincr | lung-inducible neuralized-related C3HC4 RING domain protein | 4.397e-4 | -2.529e+0 |
| cxcl16 | chemokine (C-X-C motif) ligand 16 | 1.396e-2 | -2.536e+0 |
| ptgir | prostaglandin I receptor (IP) | 7.570e-6 | -2.542e+0 |
| 4930431b09rik | RIKEN cDNA 4930431B09 gene | 2.460e-3 | -2.552e+0 |
| irak2 | interleukin-1 receptor-associated kinase 2 | 1.264e-4 | -2.563e+0 |
| lgals1 | lectin, galactose binding, soluble 1 | 5.386e-7 | -2.568e+0 |
| gpr132 | G protein-coupled receptor 132 | 8.607e-6 | -2.570e+0 |
| ugt1a9 | UDP glucuronosyltransferase 1 family, polypeptide A9 | 2.731e-4 | -2.572e+0 |
| ottmusg00000016644 | predicted gene, OTTMUSG00000016644 | 3.948e-2 | -2.572e+0 |
| gatm | glycine amidinotransferase (L-arginine:glycine amidinotransferase) | 4.220e-4 | -2.572e+0 |
| sgk1 | serum/glucocorticoid regulated kinase 1 | 3.308e-3 | -2.577e+0 |
| anxa4 | annexin A4 | 4.455e-3 | -2.578e+0 |
| hck | hemopoietic cell kinase | 5.775e-3 | -2.583e+0 |
| cd52 | CD52 antigen | 1.397e-3 | -2.583e+0 |
| nfkbie | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 1.570e-5 | -2.591e+0 |
| slamf7 | SLAM family member 7 | 1.930e-2 | -2.593e+0 |
| atf3 | activating transcription factor 3 | 1.354e-3 | -2.596e+0 |
| nab2 | Ngfi-A binding protein 2 | 6.010e-5 | -2.598e+0 |
| nlrc5 | NLR family, CARD domain containing 5 | 4.282e-3 | -2.601e+0 |
| 9630010g10rik | RIKEN cDNA 9630010G10 gene | 3.664e-3 | -2.610e+0 |
| gadd45b | growth arrest and DNA-damage-inducible 45 beta | 1.795e-4 | -2.614e+0 |
| 2010001m09rik | RIKEN cDNA 2010001M09 gene | 6.595e-5 | -2.617e+0 |
| h2-t23 | histocompatibility 2, T region locus 23 | 1.470e-4 | -2.620e+0 |
| serpina3g | serine (or cysteine) peptidase inhibitor, clade A, member 3G | 7.190e-6 | -2.625e+0 |
| stx11 | syntaxin 11 | 5.013e-5 | -2.627e+0 |
| lilrb3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 3.311e-4 | -2.655e+0 |
| 3110043o21rik | RIKEN cDNA 3110043O21 gene | 2.233e-4 | -2.657e+0 |
| mefv | Mediterranean fever | 1.220e-2 | -2.664e+0 |
| trfr2 | transferrin receptor 2 | 8.029e-5 | -2.673e+0 |
| lgmn | legumain | 3.955e-2 | -2.675e+0 |
| g0s2 | G0/G1 switch gene 2 | 3.473e-3 | -2.678e+0 |
| 1110003e01rik | RIKEN cDNA 1110003E01 gene | 5.978e-6 | -2.680e+0 |
| pqlc3 | PQ loop repeat containing | 6.130e-4 | -2.682e+0 |
| rgs16 | regulator of G-protein signaling 16 | 7.347e-6 | -2.686e+0 |
| ugt1a6a | UDP glucuronosyltransferase 1 family, polypeptide A6A | 1.406e-4 | -2.690e+0 |
| casp1 | caspase 1 | 1.108e-2 | -2.694e+0 |
| gzmc | granzyme C | 1.786e-3 | -2.696e+0 |
| scin | scinderin | 5.176e-9 | -2.702e+0 |
| adrbk2 | adrenergic receptor kinase, beta 2 | 1.809e-6 | -2.702e+0 |
| ifitm6 | interferon induced transmembrane protein 6 | 1.052e-2 | -2.705e+0 |
| runx3 | runt related transcription factor 3 | 2.576e-8 | -2.706e+0 |
| lyz2 | lysozyme 2 | 2.581e-3 | -2.722e+0 |
| ltb | lymphotoxin B | 1.065e-4 | -2.736e+0 |
| pygl | liver glycogen phosphorylase | 1.296e-6 | -2.736e+0 |
| oasl1 | 2'-5' oligoadenylate synthetase-like 1 | 1.857e-2 | -2.740e+0 |
| bc006779 | cDNA sequence BC006779 | 8.597e-5 | -2.742e+0 |
| c3 | complement component 3 | 7.847e-3 | -2.751e+0 |
| ly96 | lymphocyte antigen 96 | 7.685e-4 | -2.759e+0 |
| ifitm1 | interferon induced transmembrane protein 1 | 9.057e-6 | -2.762e+0 |
| cd72 | CD72 antigen | 4.906e-3 | -2.764e+0 |
| aw112010 | expressed sequence AW112010 | 1.198e-2 | -2.767e+0 |
| tnfsf9 | tumor necrosis factor (ligand) superfamily, member 9 | 1.861e-2 | -2.778e+0 |
| slc28a2 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 | 1.402e-3 | -2.778e+0 |
| map3k8 | mitogen-activated protein kinase kinase kinase 8 | 1.622e-4 | -2.779e+0 |
| nr4a1 | nuclear receptor subfamily 4, group A, member 1 | 1.437e-5 | -2.783e+0 |
| rab20 | RAB20, member RAS oncogene family | 2.240e-2 | -2.784e+0 |
| fcgr2b | Fc receptor, IgG, low affinity IIb | 1.764e-3 | -2.794e+0 |
| ramp3 | receptor (calcitonin) activity modifying protein 3 | 5.835e-6 | -2.797e+0 |
| cd36 | CD36 antigen | 1.604e-2 | -2.801e+0 |
| sfxn3 | sideroflexin 3 | 9.296e-7 | -2.822e+0 |
| kcnn4 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 | 2.102e-6 | -2.848e+0 |
| rrad | Ras-related associated with diabetes | 7.500e-6 | -2.850e+0 |
| niban | niban protein | 1.914e-5 | -2.860e+0 |
| 1100001h23rik | RIKEN cDNA 1100001H23 gene | 5.598e-3 | -2.862e+0 |
| phf11 | PHD finger protein 11 | 2.013e-2 | -2.865e+0 |
| c3ar1 | complement component 3a receptor 1 | 2.920e-2 | -2.874e+0 |
| hoxa9 | homeo box A9 | 4.177e-6 | -2.887e+0 |
| c1qa | complement component 1, q subcomponent, alpha polypeptide | 2.577e-2 | -2.888e+0 |
| h2-gs10 | MHC class I like protein GS10 | 6.183e-3 | -2.903e+0 |
| tgtp | T-cell specific GTPase | 1.551e-3 | -2.907e+0 |
| emr1 | EGF-like module containing, mucin-like, hormone receptor-like sequence 1 | 1.061e-2 | -2.912e+0 |
| ddx4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 1.116e-4 | -2.916e+0 |
| gbp2 | guanylate binding protein 2 | 8.019e-4 | -2.933e+0 |
| tnfrsf13c | tumor necrosis factor receptor superfamily, member 13c | 3.203e-6 | -2.940e+0 |
| 5133401h06rik | RIKEN cDNA 5133401H06 gene | 6.496e-3 | -2.951e+0 |
| ankrd57 | ankyrin repeat domain 57 | 3.022e-3 | -2.969e+0 |
| tnfsf13 | tumor necrosis factor (ligand) superfamily, member 13 | 2.261e-2 | -2.972e+0 |
| cxcr7 | chemokine (C-X-C motif) receptor 7 | 8.152e-4 | -2.975e+0 |
| itgax | integrin alpha X | 4.399e-3 | -2.976e+0 |
| fpr2 | formyl peptide receptor 2 | 1.319e-2 | -2.978e+0 |
| gbp3 | guanylate binding protein 3 | 3.750e-5 | -2.999e+0 |
| car1 | carbonic anhydrase 1 | 5.838e-5 | -3.000e+0 |
| bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 1.760e-6 | -3.004e+0 |
| smpdl3a | sphingomyelin phosphodiesterase, acid-like 3A | 3.502e-4 | -3.013e+0 |
| cd68 | CD68 antigen | 1.034e-2 | -3.020e+0 |
| ccr1 | chemokine (C-C motif) receptor 1 | 1.131e-2 | -3.026e+0 |
| ear3 | eosinophil-associated, ribonuclease A family, member 3 | 1.844e-2 | -3.029e+0 |
| isg20 | interferon-stimulated protein | 2.537e-4 | -3.029e+0 |
| ifit1 | interferon-induced protein with tetratricopeptide repeats 1 | 1.039e-2 | -3.052e+0 |
| ifit3 | interferon-induced protein with tetratricopeptide repeats 3 | 2.190e-2 | -3.062e+0 |
| rtp4 | receptor transporter protein 4 | 3.639e-4 | -3.064e+0 |
| pld4 | phospholipase D family, member 4 | 1.752e-4 | -3.075e+0 |
| 1190002h23rik | RIKEN cDNA 1190002H23 gene | 4.267e-5 | -3.083e+0 |
| slfn2 | schlafen 2 | 8.672e-3 | -3.091e+0 |
| il1rn | interleukin 1 receptor antagonist | 3.523e-2 | -3.139e+0 |
| gch1 | GTP cyclohydrolase 1 | 5.456e-5 | -3.172e+0 |
| lonrf3 | LON peptidase N-terminal domain and ring finger 3 | 6.592e-6 | -3.177e+0 |
| ptger4 | prostaglandin E receptor 4 (subtype EP4) | 3.219e-4 | -3.179e+0 |
| ifi203 | interferon activated gene 203 | 1.364e-5 | -3.183e+0 |
| relb | avian reticuloendotheliosis viral (v-rel) oncogene related B | 2.399e-5 | -3.190e+0 |
| hmox1 | heme oxygenase (decycling) 1 | 8.594e-3 | -3.206e+0 |
| pla2g7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 1.117e-2 | -3.208e+0 |
| nkg7 | natural killer cell group 7 sequence | 5.600e-6 | -3.233e+0 |
| havcr2 | hepatitis A virus cellular receptor 2 | 1.719e-3 | -3.234e+0 |
| prdm1 | PR domain containing 1, with ZNF domain | 3.497e-5 | -3.258e+0 |
| ddit4 | DNA-damage-inducible transcript 4 | 5.060e-7 | -3.271e+0 |
| oas1g | 2'-5' oligoadenylate synthetase 1G | 4.224e-4 | -3.300e+0 |
| selplg | selectin, platelet (p-selectin) ligand | 3.075e-8 | -3.302e+0 |
| ifi47 | interferon gamma inducible protein 47 | 2.756e-5 | -3.322e+0 |
| arg2 | arginase type II | 1.271e-2 | -3.326e+0 |
| ctsg | cathepsin G | 5.403e-5 | -3.341e+0 |
| clec7a | C-type lectin domain family 7, member a | 8.681e-3 | -3.353e+0 |
| il1r2 | interleukin 1 receptor, type II | 1.959e-5 | -3.373e+0 |
| parp12 | poly (ADP-ribose) polymerase family, member 12 | 4.034e-4 | -3.389e+0 |
| loc73899 | hypothetical LOC73899 | 7.028e-6 | -3.392e+0 |
| ccl6 | chemokine (C-C motif) ligand 6 | 6.899e-3 | -3.428e+0 |
| il18 | interleukin 18 | 2.600e-4 | -3.449e+0 |
| ifi204 | interferon activated gene 204 | 2.455e-2 | -3.488e+0 |
| slc11a1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 6.595e-3 | -3.492e+0 |
| 4930519l02rik | RIKEN cDNA 4930519L02 gene | 2.280e-4 | -3.494e+0 |
| casp4 | caspase 4, apoptosis-related cysteine peptidase | 4.059e-5 | -3.515e+0 |
| gm2a | GM2 ganglioside activator protein | 2.274e-5 | -3.522e+0 |
| pira6 | paired-Ig-like receptor A6 | 5.534e-5 | -3.549e+0 |
| speer1-ps1 | spermatogenesis associated glutamate (E)-rich protein 1, pseudogene 1 | 1.267e-4 | -3.576e+0 |
| ly9 | lymphocyte antigen 9 | 1.174e-4 | -3.602e+0 |
| slc15a3 | solute carrier family 15, member 3 | 1.899e-3 | -3.613e+0 |
| s100a6 | S100 calcium binding protein A6 (calcyclin) | 9.819e-4 | -3.621e+0 |
| glipr1 | GLI pathogenesis-related 1 (glioma) | 5.139e-7 | -3.629e+0 |
| il10 | interleukin 10 | 1.093e-2 | -3.636e+0 |
| clec4a3 | C-type lectin domain family 4, member a3 | 2.369e-2 | -3.674e+0 |
| basp1 | brain abundant, membrane attached signal protein 1 | 2.110e-7 | -3.688e+0 |
| stap1 | signal transducing adaptor family member 1 | 6.922e-6 | -3.690e+0 |
| 2610034m16rik | RIKEN cDNA 2610034M16 gene | 6.858e-6 | -3.693e+0 |
| lpxn | leupaxin | 6.492e-4 | -3.694e+0 |
| cybb | cytochrome b-245, beta polypeptide | 1.225e-3 | -3.700e+0 |
| areg | amphiregulin | 3.268e-3 | -3.706e+0 |
| hdc | histidine decarboxylase | 6.617e-7 | -3.714e+0 |
| ccl7 | chemokine (C-C motif) ligand 7 | 1.926e-2 | -3.727e+0 |
| 100042856 | predicted gene, 100042856 | 1.331e-6 | -3.741e+0 |
| ccr7 | chemokine (C-C motif) receptor 7 | 6.570e-5 | -3.745e+0 |
| cpa3 | carboxypeptidase A3, mast cell | 2.266e-6 | -3.768e+0 |
| ccl5 | chemokine (C-C motif) ligand 5 | 1.924e-3 | -3.781e+0 |
| oasl2 | 2'-5' oligoadenylate synthetase-like 2 | 7.120e-4 | -3.806e+0 |
| cd27 | CD27 antigen | 1.135e-6 | -3.827e+0 |
| 2210403k04rik | RIKEN cDNA 2210403K04 gene | 1.540e-6 | -3.871e+0 |
| ccl12 | chemokine (C-C motif) ligand 12 | 2.828e-2 | -3.876e+0 |
| cd74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 1.778e-3 | -3.902e+0 |
| gzmd | granzyme D | 3.662e-3 | -3.904e+0 |
| ly6a | lymphocyte antigen 6 complex, locus A | 1.298e-4 | -3.906e+0 |
| aif1 | allograft inflammatory factor 1 | 1.015e-2 | -3.916e+0 |
| pira1 | paired-Ig-like receptor A1 | 1.428e-6 | -3.940e+0 |
| pyhin1 | pyrin and HIN domain family, member 1 | 2.285e-3 | -3.945e+0 |
| ms4a6b | membrane-spanning 4-domains, subfamily A, member 6B | 2.101e-3 | -3.965e+0 |
| il1a | interleukin 1 alpha | 3.189e-3 | -3.971e+0 |
| adam8 | a disintegrin and metallopeptidase domain 8 | 4.862e-4 | -3.987e+0 |
| ms4a6c | membrane-spanning 4-domains, subfamily A, member 6C | 2.357e-3 | -3.995e+0 |
| clec4n | C-type lectin domain family 4, member n | 9.341e-3 | -4.008e+0 |
| ccrl2 | chemokine (C-C motif) receptor-like 2 | 1.104e-3 | -4.019e+0 |
| h2-aa | histocompatibility 2, class II antigen A, alpha | 6.537e-4 | -4.024e+0 |
| cxcl10 | chemokine (C-X-C motif) ligand 10 | 2.563e-5 | -4.028e+0 |
| flt3 | FMS-like tyrosine kinase 3 | 1.226e-6 | -4.070e+0 |
| ly86 | lymphocyte antigen 86 | 1.523e-3 | -4.095e+0 |
| rgs1 | regulator of G-protein signaling 1 | 1.880e-5 | -4.109e+0 |
| eg622976 | predicted gene, EG622976 | 9.563e-3 | -4.137e+0 |
| s100a4 | S100 calcium binding protein A4 | 1.321e-3 | -4.140e+0 |
| osm | oncostatin M | 9.167e-4 | -4.158e+0 |
| ccl4 | chemokine (C-C motif) ligand 4 | 4.210e-4 | -4.159e+0 |
| ccl2 | chemokine (C-C motif) ligand 2 | 6.753e-3 | -4.164e+0 |
| 0610037m15rik | RIKEN cDNA 0610037M15 gene | 8.183e-4 | -4.179e+0 |
| loc100044979 | similar to Gpr137b protein | 1.535e-5 | -4.197e+0 |
| p2ry10 | purinergic receptor P2Y, G-protein coupled 10 | 5.200e-6 | -4.200e+0 |
| rsad2 | radical S-adenosyl methionine domain containing 2 | 6.177e-4 | -4.207e+0 |
| ear2 | eosinophil-associated, ribonuclease A family, member 2 | 4.603e-3 | -4.313e+0 |
| traf1 | Tnf receptor-associated factor 1 | 5.466e-7 | -4.368e+0 |
| irg1 | immunoresponsive gene 1 | 1.835e-4 | -4.384e+0 |
| h2-eb1 | histocompatibility 2, class II antigen E beta | 7.570e-4 | -4.394e+0 |
| cd24a | CD24a antigen | 1.774e-8 | -4.403e+0 |
| ccl9 | chemokine (C-C motif) ligand 9 | 2.429e-4 | -4.408e+0 |
| cxcl1 | chemokine (C-X-C motif) ligand 1 | 2.207e-3 | -4.497e+0 |
| tgfbi | transforming growth factor, beta induced | 5.300e-4 | -4.506e+0 |
| ly6c1 | lymphocyte antigen 6 complex, locus C1 | 2.640e-3 | -4.540e+0 |
| ifi27 | interferon, alpha-inducible protein 27 | 2.049e-3 | -4.592e+0 |
| ai607873 | expressed sequence AI607873 | 2.763e-3 | -4.622e+0 |
| rmcs5 | response to metastatic cancers 5 | 1.720e-4 | -4.661e+0 |
| cd48 | CD48 antigen | 6.548e-6 | -4.661e+0 |
| ai662270 | expressed sequence AI662270 | 1.488e-8 | -4.717e+0 |
| il6 | interleukin 6 | 1.159e-3 | -4.754e+0 |
| ms4a4c | membrane-spanning 4-domains, subfamily A, member 4C | 3.473e-3 | -4.784e+0 |
| clec4d | C-type lectin domain family 4, member d | 2.550e-5 | -4.788e+0 |
| gzmb | granzyme B | 1.460e-7 | -4.819e+0 |
| 1810015c04rik | RIKEN cDNA 1810015C04 gene | 1.258e-7 | -4.876e+0 |
| h2-q7 | histocompatibility 2, Q region locus 7 | 1.476e-4 | -4.883e+0 |
| olr1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 4.303e-5 | -4.904e+0 |
| mpeg1 | macrophage expressed gene 1 | 2.835e-4 | -5.094e+0 |
| aa467197 | expressed sequence AA467197 | 6.020e-5 | -5.242e+0 |
| s100a8 | S100 calcium binding protein A8 (calgranulin A) | 8.578e-4 | -5.258e+0 |
| s100a9 | S100 calcium binding protein A9 (calgranulin B) | 7.753e-4 | -5.269e+0 |
| chi3l3 | chitinase 3-like 3 | 1.573e-3 | -5.368e+0 |
| cxcr4 | chemokine (C-X-C motif) receptor 4 | 1.691e-6 | -5.414e+0 |
| cxcl3 | chemokine (C-X-C motif) ligand 3 | 6.475e-4 | -5.477e+0 |
| clec4e | C-type lectin domain family 4, member e | 1.497e-5 | -5.521e+0 |
| slfn4 | schlafen 4 | 5.362e-4 | -5.563e+0 |
| cd14 | CD14 antigen | 5.281e-4 | -5.648e+0 |
| ottmusg00000000971 | predicted gene, OTTMUSG00000000971 | 1.229e-5 | -5.671e+0 |
| il1b | interleukin 1 beta | 2.905e-4 | -5.695e+0 |
| spp1 | secreted phosphoprotein 1 | 4.404e-4 | -5.893e+0 |
| ifi205 | interferon activated gene 205 | 1.993e-6 | -5.960e+0 |
| cxcl2 | chemokine (C-X-C motif) ligand 2 | 1.790e-5 | -6.000e+0 |
| ctss | cathepsin S | 5.452e-5 | -6.005e+0 |
| lilrb4 | leukocyte immunoglobulin-like receptor, subfamily B, member 4 | 2.434e-7 | -6.066e+0 |
| bcl2a1a | B-cell leukemia/lymphoma 2 related protein A1a | 1.531e-5 | -6.066e+0 |
| bhlhb2 | basic helix-loop-helix domain containing, class B2 | 8.666e-9 | -6.183e+0 |
| lgals3 | lectin, galactose binding, soluble 3 | 6.217e-5 | -6.295e+0 |
| cd83 | CD83 antigen | 4.405e-7 | -6.753e+0 |